Business Segments · Net revenue
Diagnostics and Genomics — Net revenue
Agilent Technologies Diagnostics and Genomics — Net revenue increased by 14.8% to $442.00M in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 24.2%, from $356.00M to $442.00M. Over 3 years (FY 2021 to FY 2024), Diagnostics and Genomics — Net revenue shows an upward trend with a 8.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2021
Last reportedQ1 2026
Rolls up toTotal Revenue
How to read this metric
An increase suggests strong market adoption and competitive positioning of the segment's diagnostic and genomic technologies.
Detailed definition
This represents the total gross sales generated by the diagnostics and genomics segment after deducting returns, allowan...
Peer comparison
Standard revenue reporting across all life science and diagnostic equipment manufacturers.
Metric ID:
a_segment_diagnostics_and_genomics_net_revenueHistorical Data
15 periods
| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $315.00M | $346.00M | $341.00M | $339.00M | $358.00M | $340.00M | $352.00M | $342.00M | $362.00M | $349.00M | $356.00M | $407.00M | $417.00M | $385.00M | $442.00M |
| QoQ Change | — | +9.8% | -1.4% | -0.6% | +5.6% | -5.0% | +3.5% | -2.8% | +5.8% | -3.6% | +2.0% | +14.3% | +2.5% | -7.7% | +14.8% |
| YoY Change | — | — | — | — | +13.7% | -1.7% | +3.2% | +0.9% | +1.1% | +2.6% | +1.1% | +19.0% | +15.2% | +10.3% | +24.2% |
Range$315.00M – $442.00M
CAGR+10.2%
Avg YoY Growth+8.1%
Median YoY Growth+3.2%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Agilent Technologies's diagnostics and genomics — net revenue?
- Agilent Technologies (A) reported diagnostics and genomics — net revenue of $442.00M in Q3 2024.
- How has Agilent Technologies's diagnostics and genomics — net revenue changed year-over-year?
- Agilent Technologies's diagnostics and genomics — net revenue increased by 24.2% year-over-year, from $356.00M to $442.00M.
- What is the long-term trend for Agilent Technologies's diagnostics and genomics — net revenue?
- Over 3 years (2021 to 2024), Agilent Technologies's diagnostics and genomics — net revenue has grown at a 8.4% compound annual growth rate (CAGR), from $1.30B to $1.65B.
- What does diagnostics and genomics — net revenue mean?
- Total sales generated by the diagnostics and genomics business segment.